Gilead's latest Covid study finds mixed results for 'moderate' patients — and that may be good
June 01, 2020 at 11:55 AM EDT
The late-stage study is the third with results of remdesivir against Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|